Oncology Books
Cambridge University Press Sulfur Analogues of Polycyclic Aromatic Hydrocarbons Thiaarenes
Book SynopsisFirst published in 1990. Sulfur containing polycyclic aromatic compounds (thiaarenes) play a potentially important role in environmentally induced cancers. The main sources of these compounds being fossil fuels such as coal, petroleum and shale oils from which they are released either directly or via combustion into the environment.Table of Contents1. General chapter on thiaarenes; 2. Compounds; 3. References.
£42.99
Cambridge University Press Dibenzanthracenes and Environmental Carcinogenesis
Book SynopsisFirst published in 1992, this volume provides a systematic survey of the dibenzanthracenes and of their chemical, physiochemical and biological properties. This is the first comprehensive account of this important group of environmental pollutants and carcinogens. It will be of interest to all scientists studying carcinogenesis, and the mutagenicity and toxicology of environmental pollutants.Table of Contents1. Structure, nomenclature and physical/chemical properties; 2. Preparation of dibenzanthracenes; 3. Occurrence and exposure; 4. Analysis and spectra; 5. Metabolism and cellular interactions; 6. Mutagenicity and toxicity; 7. Carcinogenicity; 8. Structure-activity relationships; 9. References; 10. Glossary; 11. Index.
£36.99
Cambridge University Press The Chemistry and Biology of Benzaanthracenes
Book SynopsisFirst published in 1988, this volume surveys the chemical synthesis and biological activity of the benz[a]anthracenes.Table of ContentsPart I. Chemistry: 1. Synthetic routes from benzenes and naphthalenes; 2. Synthetic routes from anthracenes (A-ring formation); 3. Synthetic routes from anthracenes (D-ring formation); Part II. Biology: 8. Metabolism; 9. DNA, RNA and protein interactions; 10. Mutagenicity; 11. Carciogenicity; References; Index.
£36.99
Cambridge University Press Drug Resistance in Cancer
Book SynopsisThis book provides an accessible yet sophisticated account of the mechanisms responsible for drug resistance in cancer. In addition, the authors use clearly explained mathematical models to provide an insight into tumour development and the effectiveness and limitations of drug treatment.Trade Review'However, this volume provides a very good overview of the drug resistance field with special emphasis on mathematical models and can be recommended to everyone interested in the field. Even those who see math as an alien subject will find this book useful, since the mathematical portions of the text have been kept as straightforward as possible. The book is a good source of references and suggestions for further reading and should interest a wide readership including clinicians, molecular biologists, and researchers interested in tumor growth, tumor killing and mutation models.' V. Spataro, Annals of Oncology'… required reading for all trainees in oncology.' Paul P. Carbone, OncologyTable of ContentsPreface; 1. The biological basis of cancer and the problem of drug resistance; 2. Tumour growth, stem cells and experimental chemotherapy; 3. Molecular aspects of drug resistance; 4. Quantitative descriptions of the origins of drug resistance; 5. Development and exploration of the random mutation model for drug resistance; 6. Extensions of the random mutation model for drug resistance; 7. Clinical predictions of the random mutation model; 8. Directed versus random mutation and the problem of intrinsic resistance; 9. Some final thoughts on the problem of drug resistance; Index.
£49.99
Cambridge University Press Cancer Screening
Book SynopsisScreening is regarded as a cost-effective and clinically useful approach for the early diagnosis of several malignancies, especially common cancers. This 1991 publication was organized by the International Union Against Cancer (UICC), one of the world's foremost agencies in the field of cancer epidemiology and control.Table of ContentsPreface; Part I. Screening for Breast Cancer: State of the Art on Breast Cancer Screening: 1. Sensitivity and specificity of screening in the UK trial of early detection of breast cancer; 2. Screening for breast cancer in Finland; 3. The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumour characteristics; 4. The Malmö mammographic screening trial; 5. The Canadian national breast screening study; 6. The USSR/Germany/WHO BSE study and global strategies for the control of breast cancer; 7. A cost-effectiveness approach to breast cancer screening; 8. Summary of the discussion on breast cancer screening; Part II. Screening for Colorectal Cancer: State of the Art on Screening for Colorectal Cancer: 9. Colon cancer control study: status and current issues; 10. An update on the Nottingham trial of faecal occult blood screening and rescreening of 51 325 subject; 12. Interim report on a randomised trial of screening for colorectal cancer with Hemoccult-II; 13. Case-control evaluation of colorectal cancer screening in the Federal Republic of Germany; 14. Summary of the discussion on colorectal cancer screening; Part III. Screening of Cancer for the Cervix: State of the Art on Screening for Cancer of the Cervix: 15. The natural history of cancer of the cervix, and the implications for screening policy; 16. Effect of organized screening on the risk of cervical cancer in the Nordic countries; 17. The organisation of cervical screening in England and Wales; 18. Indications for colposcopy from a UK viewpoint; 19. Screening for cervix cancer in developing countries; 20. Summary of the discussion on screening for cancer of the cervix; Part IV. Screening for Ovarian Cancer: State of the Art on Screening for Ovarian Cancer: 21. Tumour markers in screening for ovarian cancer; 22. Phase I investigation for early diagnosis of ovarian carcinoma; what problems are to be expected in a larger screening programme?; 23. Screening for ovarian cancer; 24. Summary of the discussion on screening for ovarian cancer; Part V. Screening for Malignant Melanoma: State of the Art on Screening for Melanoma: 25. Screening and early diagnosis for melanoma in Australia and New Zealand; 26. Screening for melanoma in the UK; 27. Screening for melanoma/skin cancer in the United States; 28. The dysplastic naevus syndrome: implications for screening; 29. Summary of the discussion on screening for melanoma of the skin; Part VI. Screening for Prostate Cancer: State of the Art on Screening for Prostate Cancer: 30. Issue in screening for prostate cancer; 31. Available screening tests for prostate cancer; 32. Evaluation of screening for prostate, lung and colorectal cancers :the PLC trial; 33. Summary of the discussion on screening for cancer of the prostate; Part VII. Screening for Neuroblastoma: State of the Art on Screening for Neuroblastoma: 34. Neuroblastoma: studies in Japan; 35. Screening for neuroblastoma, background, preliminary experience in the North of England and proposals for an evaluative study; 36. Summary of the discussion on screening for neuroblastoma; Part VIII. Screening for Stomach Cancer: State of the Art on Screening for Stomach Cancer: 37. Evaluation of mass screening programme for stomach cancer in Japan; 38. Summary for the discussion of screening for stomach cancer; Part IX. Screening for Nasopharyngeal Cancer: State of the Art on Screening for Nasopharyngeal Cancer: 39. Screening for nasopharyngeal carcinoma; 40. Summary of the discussion on screening for nasopharyngeal cancer; Part X. Methodological Issues: 41. Surrogate measures in the design of breast screening trials; 42. Recent developments in cancer screening modeling; 43. Case-control studies of screening; 44. Summary of the discussion on new approaches to the evaluation of screening.
£55.99
Cambridge University Press Supplementary Mutagenicity Tests
Book SynopsisOriginally published in 1993, this volume describes a complementary selection of tests to those described in the companion volume Basic Mutagenicity Tests (Cambridge University Press, 1990). These supplementary tests were used to assess risks of in vitro mutagenicity in those instances where the basic safety tests were inconclusive.Table of ContentsSteering group; Contributors; List of abbreviations; 1. Introduction D. J. Kirkland; 2. Geonotoxicity studies using yeast cultures T. M. Brooks et al.; 3. In vivo rat liver UDS assay J. C. Kennelly et al.; 4. Measurement of covalent binding to DNA in vivo C. N. Martin et al.; 5. Mammalian germ cell cytogenics C. Tease et al.; 6. The rodent dominant lethal assay L. M. Holmstrom et al.; Index.
£30.44
Cambridge University Press Tumor Immunology
Book SynopsisThis 1996 volume reviewed advances in the field of human tumour immunology, particularly in relation to the potential for immune intervention in preventing or treating tumours. The contributors survey advances in the understanding of the relationship between the cancer cell and the immune response at the time of publication.Trade ReviewReview of the hardback: ' … will serve as a good text-book on cancer immunology and/or an excellent reference source on its individual topics. It can be recommended to clinicians, researchers and even undergraduates wishing to deepen their knowledge of this field.' Anton B. Alexandfoff, Immunology NewsReview of the hardback: ' … an excellent source of information which will be most helpful to the clinicians involved or interested in the various clinical vaccine trials that have been or will be implemented in the next five years.' J.-C. Cerottini, Annals of OncologyReview of the hardback: ' … there is much to commend the book. It will appeal mainly to clinicians and scientists who have some basic knowledge of cancer and immunology.' J. A. Ledermann, Journal of the Royal Society of MedicineReview of the hardback: ' … a balanced overview of the state-of-the-art, with special emphasis on the new potential for cancer immunotherapy … an excellent source of information'. Annals of OncologyTable of ContentsContributors; Series Editor's Preface; Abbreviations; 1. Introduction and historical perspectives Michael Browning and A. G. Dalgleish; 2. The immunosurveillance of cancer: specific and non-specific mechanisms Richard G. Vile, Heung Chong and Sina Dorudi; 3. Antigen processing and presentation Nicholas C. Testifo and Michael Wang; 4. The role of the MHC class I in tumor immunity Michael Browning; 5. Human tumor antigens recognized by Cytolytic T Lymphocytes Pierre G Coulie; 6. Peptide-specific CTL directed against viral oncogene products Mariet C.W. Feltkamp, Cornelis J. M. Melief and W. Martin Kast; 7. Cellular oncogenes for tumor immunity: immunotherapy Hans J. Strauss and A. Maria Dahl; 8. Co-stimulatory molecules and their role in tumour immunity A. G. Dalgleish; 9. The role of cytokines in tumour rejection Guido Forni and Robin Foa; 10. Inhibition of nonhemopoietic cancer cell growth by Interleukin-4 and related cytokines Dave S. B. Hoon, Takashi Morisaki and Richard Essner; 11. Current concepts concerning melanoma vaccines Donald L. Morton and Mepur H. Ravindranath; 12. Immune responses to mucins Rosalind A. Graham and Joyce Taylor-Papadimitriou; 13. Heat shock protein-peptide complexes: pan-valent vaccines against cancers and infectious diseases Ryuichiro Suto and Pramod K. Srivastave; 14. The potential of gene transfer to alter the immune response to tumors Bernard A. Fox and Gary J. Nabel; 15. Applications of antibody gene technology Robert E. Hawkins and Kerry A. Chester; Index.
£50.81
Cambridge University Press Molecular Endocrinology of Cancer
Book SynopsisThis 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer, including the molecular basis for the autocrine and paracrine regulation of cancer, molecular strategies for cancer detection, preventive strategies in limiting the epidemic of hormonally related cancers, and treatment approaches.Table of ContentsContributor list; Part I. The Regulation of Cancer: 1. The type 1 growth factor receptor family, their ligands and their role in human cancers T. Rajkumar and W. J. Gullick; 2. The fibroblast growth factor family and their receptors Pita Enriquez Harris and John K. Heath; 3. The biological role of transforming growth factor beta in cancer development Bradley A. Arrick and Rik Derynck; 4. Bombesin and its receptor Michael J. Seckl and Enrique Rozengurt; 5. Gonadotrophin-releasing hormone and its receptor Karin A. Eidne and Lorraine Anderson; 6. Cytokines T. Hamblin; Part II. The Prevention of Endocrine-Dependent Tumours: 7. Familial Cancer Audrey D. Goddard and Donald M. Black; 8. Diet Peter Boyle and Patrick Maisonneuve; 9. Breast cancer: new biological approaches to treatment Robert B. Dickson and Robert Clarke; 10. The biological basis for the treatment of prostate cancer Jonathan Waxman, Andrew Stubbs and Hardev Pandha; 11. Carcinoid tumours S. Bloom and P. Hammond; Part III. Endocrine Complications of Cancer Treatment: 12. Humoral hypercalcaemia John J. Wysolmerski and Arthur E. Braodus; 13. Anaemia of cancer Carole B. Miller and Jerry L. Spivak; Index.
£49.99
Cambridge University Press Myelodysplastic Syndromes
Book SynopsisWritten by leading international specialists in the field, this 2006 book describes the major insights into the clinical classification, underlying biological mechanisms and treatment of the myelodysplastic syndromes.Table of ContentsPreface Peter Greenberg; 1. Clinical and prognostic characterization of Myelodysplastic Syndrome Peter Greenberg; 2. Morphologic classifications of Myelodysplastic Syndrome: French-American-British and the World Health Organization Richard Brunning; 3. Pathogenetic mechanisms underlying Myelodysplastic Syndrome Peter Greenberg; 4. Cytogenetic abnormalities in Myelodysplastic Syndrome Harold J. Olney and Michelle M. Le Beau; 5. Molecular mechanisms and gene expression patterns in Myelodysplastic Syndrome Wolf-Karsten Hofmann and Phillip Koeffler; 6. Immunologic mechanisms and treatment of Myelodysplastic Syndrome A. John Barrett, Elaine Sloand and Neal S. Young; 7. Biologically targeted therapies for Myelodysplastic Syndrome Andrew Buresh and Alan List; 8. Supportive care in Myelodysplastic Syndrome: hemopoietic cytokines and iron chelation therapy Jason Gotlib and Peter Greenberg; 9. Hematopoietic cell transplantation options in Myelodysplastic Syndrome Joachim Deeg and Bart Scott; 10. Health-related quality of life in Myelodysplastic Syndrome: conceptualization, measurement and implications Mary Thomas.
£49.23
Cambridge University Press The Economics of Cancer Care
Book SynopsisThis 2006 book analyses tensions between those paying for cancer care, those providing care and those marketing drugs and devices. Written by a leading health economist and oncologist, this was the first comprehensive book on the economics of cancer care and remains of interest to health professionals and policy makers alike.Table of Contents1. Introduction; 2. Prevention; 3. Screening; 4. Diagnostics; 5. Surgery; 6. Radiotherapy; 7. Chemotherapy; 8. Moving towards the new model: international comparison; 9. The new agenda; 10. Cancer's economic impact on society; 11. Improving the patient experience.
£37.99
McFarland & Co Inc A Year in the Life of a Dead Woman
Book Synopsis Perhaps I should have realized that cancer runs in my family. After all, three grandparents and my father and brother perished from this disease. Yet, when I received my colorectal cancer diagnosis, I was surprised. I never expected to be primarily identified as a cancer patient. Following a typical combination of chemotherapy, radiation, surgery, and more chemo, I was presumably cancer-free when my post-treatment scans looked clean. Nonetheless, within a year I received a terminal diagnosis; cancer had metastasized in my lungs. Thus began my year as a dead woman--a time of chaotic emotions, new priorities, and rapid-fire plans and changes. Expecting the unexpected became a theme in my life, but the things that turned out to be most shocking are social, familial, and even my expectations about what is realistic for a dead woman to be or do. Preconceptions about a terminal cancer diagnosis frequently are based on popular culture depictions of cancer and dying, whic
£14.24
McFarland & Co Inc Navigating Glioblastoma
Book Synopsis A stale marriage. A deadly diagnosis. For Sally Connolly, three years of struggle followed her husband Peter''s surgery for terminal brain cancer at age 61. Choosing treatment options that interfered least with his career, Peter focused his limited energy on work, with little left for his family, further straining the marriage during his remaining days. Connolly''s clear-eyed and affecting memoir recounts their wrangling over gender roles, money management, domestic decisions and lifestyle changes. Through their traumatic journey, they find humor and comfort in unexpected places.Table of Contents Acknowledgments vi Preface 1 1. Gobsmacked 3 2. Dynamics 9 3. Surgery 13 4. Recovery at Home 20 5. Preliminaries to Treatment 27 6. Beginning the Regimen 32 7. Lifelines 38 8. Family 42 9. Finances 45 10. Life 52 11. Temodar 66 12. Next Steps 87 13. Here We Go Again 118 14. Surgery Again 134 15. Rehab 143 16. Home and Back Again 148 17. Retired? 15318. Into the Unknown 164 19. The White Flag 171 20. Next 180 21. Rest and Recovery 186 Appendix: Glio-What? 191 Chapter Notes 195 References 197 Index 199
£14.24
McFarland & Co Inc Standing at Waters Edge
Book Synopsis Janice Post-White was an oncology nurse who thought she knew what life with cancer was about--until her four-year-old son was diagnosed with leukemia. While he drew pictures to process his emotions, she buried her feelings and threw herself into managing a dual role as a medical professional and mother. Her memoir shares her son''s perspective as a young cancer patient and teen survivor, and explores her own personal and professional insights on survivorship, resilience, healing and what facing death can teach us about living.Table of ContentsPrefaceIntroductionPart I. The First Year: Getting Through 1. January 9, 1997, 2:40 p.m. 2. As the Seasons Change 3. Diagnosis 4. The Plan 5. The Training 6. The First Week 7. Finding Our Way 8. New Identities, New Perspectives 9. Why Cancer? Why Now? Why Us?10. Surviving11. I Just Want to Live in the Moment12. And How Is Mom?13. Who Is This Child?14. Finding Normal15. Sailing ForwardPart II. Treatment Years 2–3: The New Normal 16. Expectations17. Always on Call18. Can't Escape Cancer19. Decisions, Decisions20. The Last Lap21. Celebrate!Part III. The Decade After: Moving22. Facing Fears23. Wake-Up Call24. Hawaii as Refuge25. Reclaiming Childhood26. Taking On27. It's Okay to Cry28. Letting Go29. Shadows of the HeartEpilogueAcknowledgmentsBibliographyIndex
£14.24
Taylor & Francis Ltd Understanding Radiation Biology From DNA Damage
Book SynopsisThis book provides a qualitative and quantitative exploration of the action of radiation on living matter which leads to a complete and coherent interpretation of radiation biology. It takes readers from radiation-induced molecular damage in the nucleus of the cell and links this damage to cellular effects such as cell killing, chromosome aberrations and mutations before exploring organ damage, organism lethality and cancer induction. It also deals with radiological protection concepts and the difficulties of predicting the doseeffect relationship for low-dose and dose rate radiation risk. The book ends with separate chapters dealing with the effects of UV light exposure and risk classification of chemical mutagens, both of which are derived by logical extensions of the radiation model. This book will provide the basic foundations of radiation biology for undergraduate and graduate students in medical physics, biomedical engineering, radiological protection, medicine, radiology andTrade Review“This is a textbook on the understanding of radiation biology, which covers the basic principles governing the action of radiation on living matter. The book is well organized and easy to read. It is designed as an alternative or even complementary to other established books in the fields of radiation biology, radiotherapy, and radiological protection. Moreover, the plethora of mathematical formulas provided makes it easy to translate the presented theoretical concepts into practical tools in the clinic. The contents of the book correlate well with the required topics in preparation for the American Board of Radiology (ABR) board examinations.The most common aspects of radiation biology have successfully been addressed and presented in a way that satisfies the educational and practical goals of the book. The findings of more recent studies have been included. The book also expands to new fields such as ultraviolet light and genotoxicology. The book covers all the necessary theory, examples, and formulas that are useful to radiation biologists, radiation oncology physicians, and medical physicists (professionals and residents). The reference list at the end of the book is a great resource for individuals who want to further expand their literature investigation. This book is primarily designed to cover the needs of radiation biologists, radiation oncology physicians, and medical physicists. It can also be a useful reference for medical dosimetrists and therapy technologists. For faculty and established practitioners, it can serve as a great supplemental resource for dealing with radiation biology problems in the classroom or clinic.The book presents a coherent, quantitative, and qualitative theory of radiation biology, which has been developed and expanded over the years from the 1970s to present. It follows a practical approach providing the mathematical formulas that would allow for an intuitive implementation of the theoretical concepts in the clinic. It can help biologists and radiation oncology and medical physics residents build their background knowledge and understanding of why and how things happen in the clinical environment. Furthermore, it can serve as a quick and comprehensive review of the basic principles and concepts in the field of radiation biology. I recommend this textbook as a teaching tool for biology and medical physics training programs as well as for radiation oncology and medical physics residency programs.”—Panayiotis Mavroidis, PhD (University of North Carolina at Chapel Hill) in Doody’s Core Titles Review 2022.Table of ContentsPART I: Ionising Radiation Effects. 1. The Molecular Model and DNA Double Strand Breaks. 2. The Molecular Model for Cellular Effects. 3. The Link from Molecular Lesion to Cellular Effects. 4. DNA Double Strand Breaks and Chromosomal Aberrations. 5. The Effect of Dose Rate, Fractionation and Post-Irradiation Repair. 6. Radiation Quality. 7. Radiation-Induced Cancer. 8. Radiation-Induced Lethality. 9 Radiological Protection. PART II: Ultraviolet Light Effects. 10. The Molecular Model for the Cytotoxic Action of UV Light. PART III: Genotoxicology. 11. An Assessment of the Risk of Chemical Mutagens.
£240.00
Taylor & Francis Ltd Viral Therapy of Human Cancers
Book SynopsisFeaturing contributions from nearly 30 leading authorities, this pioneering work gauges the potential for viruses to act as oncolytic and anti-tumor agents for the treatment of cancers in humans-detailing the cancer-combative properties exhibited by viruses in nature, genetically engineered viruses, and viral oncolysates as evidenced in basic and experimental studies.Table of ContentsIntroduction o Progressive Development of the Viral Therapy of Human Cancers: A Personal Narrative Account Joseph G. Sinkovics o New Biological Therapeutics: Competitors or Collaborators in Viral Therapy for Human Cancers Joseph G. Sinkovics o Naturally Oncolytic Viruses o Measles Virus: Improving Natural Oncolytic Properties by Genetic Engineering Christoph Springfield, Adele Fielding, Kah-Whye Peng, Eva Galanis, Stephen J. Russell, and Roberto Cattaneo o Newcastle Disease Virus: Anti-tumor Immune Memory and Its Activation for Control of Residual Tumor Cells and Improvement of Patient Survival Volker Schirrmacher o Newcastle Disease Virus: Its Oncolytic Properties Joseph C. Horvath o Influenza A Viruses with Deletions in the NS1 Gene: A Rational Approach to Develop Oncolytic Viruses Michael Bergmann and Thomas Muster o Vesicular Stomatitis Virus: An Oncolytic Agent Rebecca A. C. Taylor, Jennifer M. Paterson, and John C. Bell o Parvoviruses as Anti-Cancer Agents Jean Rommelaere, Nathalia Giese, Celina Cziepluch, and Jan J. Cornelis o Viral Oncolysates o Newcastle Disease Virus Oncolysate in the Management of Stage III (AJCC) Malignant Melanoma William A. Cassel, Douglas R. Murray, and Zbigniew L. Olkowski o Vaccinia Viral Lysates in Immunotherapy of Melanoma Peter Hersey o Genetically Engineered Oncolytic Viruses o Fusogenic Oncolytic Herpes Simplex Viruses for Therapy of Solid Tumors Xinping Fu, Mikihito Nakamori, and Xiaoliu Zhang o Poliovirus Recombinants Against Malignant Glioma Melinda Merrill, David Solecki, and Matthias Gromeier o Oncolytic Viruses that Depend on Loss of RB or p53 Frank McCormick
£59.99
Taylor & Francis Inc Radiomics and Radiogenomics
Book SynopsisRadiomics and Radiogenomics: Technical Basis and Clinical Applications provides a first summary of the overlapping fields of radiomics and radiogenomics, showcasing how they are being used to evaluate disease characteristics and correlate with treatment response and patient prognosis. It explains the fundamental principles, technical bases, and clinical applications with a focus on oncology. The book's expert authors present computational approaches for extracting imaging features that help to detect and characterize disease tissues for improving diagnosis, prognosis, and evaluation of therapy response. This book is intended for audiences including imaging scientists, medical physicists, as well as medical professionals and specialists such as diagnostic radiologists, radiation oncologists, and medical oncologists.Features Provides a first complete overview of the technical underpinnings and clinical applications of radiomics and radiogenomics Trade Review "Despite an abundance of research papers and some review articles, there have not been many comprehensive books devoted to these special audiences. Two first‐edition books published in 2019 by the Taylor and Francis Group, Radiomics and Radiogenomics (edited by Ruijiang Li, Lei Xing, Sandy Napel, and Daniel L. Rubin) and Big Data in Radiation Oncology (edited by Jun Deng and Lei Xing), have opportunely filled this void, and provided a comprehensive review as well as valuable insights on these key new advances. .... From these two books, readers can gain a fundamental understanding of radiomic feature definition and computation, processing steps (such as voxel resampling, MRI field bias correction and normalization, and other data harmonization), and processing parameters (such as fixed bin size vs fixed bin number and voxel neighborhood size). Readers can also develop a deeper appreciation of proper data management in modeling from both texts. As such, the technical knowledge from the books can assist researchers in optimizing their own study design."-Dandan Zheng, in the Journal of Applied Clinical Medical Physics, July 2020 Table of Contents Part I: Introduction 1. Principles and rationale of radiomics and radiogenomics Sandy Napel Part II: Technical Basis 2. Imaging informatics: an overview Assaf Hoogi, Daniel Rubin 3. Quantitative imaging using CT Lin Lu, Lawrence H. Schwartz, Binsheng Zhao 4. Quantitative PET/CT for radiomics Stephen R. Bowen, Paul E. Kinahan, George A. Sandison, Matthew J. Nyflot 5. Common techniques of quantitative MRI David Hormuth II, Jack Virostko, Ashley Stokes, Adrienne Dula, Anna G. Sorace, Jennifer G. Whisenant, Jared Weis, C. Chad Quarles, Michael I. Miga, Thomas E. Yankeelov 6. Tumor segmentation Spyridon Bakas, Rhea Chitalia, Despina Kontos, Yong Fan, Christos Davatzikos 7. Habitat imaging of tumor evolution by magnetic resonance imaging (MRI) Bruna Victorasso Jardim-Perassi, Gary Martinez, Robert Gillies 8. Feature extraction and qualification Lise Wei, Issam El Naqa 9. Predictive modeling, machine learning, and statistical issues Panagiotis Korfiatis, Timothy L. Kline, Zeynettin Akkus, Kenneth Philbrick, Bradley J. Erikson 10. Radiogenomics: rationale and methods Olivier Gevaert 11. Resources and datasets for radiomics Ken Chang, Andrew Beers, James Brown, Jayashree Kalpathy-Cramer Part III: Clinical Applications 12. Roles of radiomics and radiogenomics in clinical practice Tianyue Niu, Xiaoli Sun, Pengfei Yang, Guohong Cao, Khin K. Tha, Hiroki Shirato, Kathleen Horst, Lei Xing 13. Brain cancer William D. Dunn Jr, Rivka Colen 14. Breast cancer Hui Li, Maryellen L. Giger 15. Lung cancer Dong Di, Jie Tian, Shuo Wang 16. The essence of R in head and neck cancer Hesham Elhalawani, Arvind Rao, Clifton D. Fuller 17. Gastrointestinal cancers Zaiyi Liu 18. Radiomics in genitourinary cancers: prostate cancer Satish Viswanath, Anant Madabhushi 19. Radiomics analysis for gynecologic cancers Harini Veeraraghavan 20. Applications of imaging genomics beyond oncology Xiaohui Yao, Jingwen Yan, Li Shen Part IV: Future Outlook 21. Quantitative imaging to guide mechanism based modeling of cancer David A. Hormouth II, Matthew T. McKenna, Thomas E. Yankeelov 22. Looking Ahead: Opportunities and Challenges in Radiomics and Radiogenomics Ruijiang Li, Yan Wu, Michael Gensheimer, Masoud Badiei Khuzani, Lei Xing
£215.00
CRC Press Pharmacotherapy of Cachexia
Book SynopsisAlthough a wealth of information can be found scattered throughout periodicals and research papers, tracking down the most effective treatment for a heterogeneous syndrome such as cachexia can be problematic. Edited by experts in the field, with contributions from a multidisciplinary panel, Pharmacotherapy of Cachexia is the first book devoted solely to the treatment of cachexia with a focus on pharmacotherapeutic aspects. The book discusses the various aspects of the syndrome and compares and contrasts its diverse treatment options. It explores the topic from a theoretical and practical perspective and provides an overview of currently available and future treatment. The first half of the book includes coverage of pathophysiology, associated diseases, and general therapeutic aspects. The subsequent sections devoted to pharmacotherapy cover drugs in clinical use, drugs in research and development, and the final section focuses on potential future advancements. NumeroTable of ContentsPreface. Pathophysiology of Cachexia. Diseases Associated with Cachexia. General Therapeutic Aspects. Drugs in Clinical Use. Drugs in Research or Development. Future Developments. Perspectives and Outlook.
£93.72
Baywood Publishing Company Inc Robbery and Redemption
Book SynopsisFirst Published in 2017. This volume is a totally candid account about the facts and feelings surrounding the diagnosis of and battle against lung cancera battle the author waged with every ounce of his being. It has an enlightening quality because he shares how he transformed his previous knowledge of family dynamics, coping strategies, and empowerment into wisdom. He shares his journey of taking the knowledge from the Before Cancer phase of his life, and like an alchemist, converting one raw materialhis life and his diagnosis and battleinto an element quite unlike the original. Robbery and Redemption: Cancer as Identity Theft is chock-full of wisdom that has been learned the old fashioned, visceral wayfrom lived experience and keen reflection. This personal, upfront, rubber-hit-the-road treatise is a gift from the author to each reader. It is his wise interpretation of his own experiences of integrating values, problem solving, and coping strategies.Table of ContentsForeword Acknowledgments INTRODUCTION Read the Introduction now CHAPTER 1 The Dream CHAPTER 2 Through the Looking Glass CHAPTER 3 The Cancer Journey and Detours Along the Way CHAPTER 4 Resolving to Battle the Bully CHAPTER 5 Communicating with Cancer CHAPTER 6 Trying To Be An Exceptional Patient CHAPTER 7 A Cancer Apprentice: Lessons in Redemption EPILOGUE: Remembering Craig Index
£137.75
John Wiley & Sons Oncology Nurse Navigation Transitioning into th
Book Synopsis
£42.75
Taylor & Francis Inc An Introduction to Physical Oncology
Book SynopsisPhysical oncology has the potential to revolutionize cancer research and treatment. The fundamental rationale behind this approach is that physical processes, such as transport mechanisms for drug molecules within tissue and forces exchanged by cancer cells with tissue, may play an equally important role as biological processes in influencing progression and treatment outcome. This book introduces the emerging field of physical oncology to a general audience, with a focus on recent breakthroughs that help in the design and discovery of more effective cancer treatments. It describes how novel mathematical models of physical transport processes incorporate patient tissue and imaging data routinely produced in the clinic to predict the efficacy of many cancer treatment approaches, including chemotherapy and radiation therapy. By helping to identify which therapies would be most beneficial for an individual patient, and quantifying their effects prior to actual implemTrade Review"The application of concepts and tools from the physical sciences will fundamentally change our understanding of cancer. These novel insights will impact the way we diagnose malignant tumors and, ultimately, they should lead to new and patient-specific paths to treat the disease more successfully. The authors are at the forefront of this most promising endeavor and they have produced a book that, ranging from chemotherapy response to immunotherapy modeling, highlights both critical research accomplishments and early clinical applications. This up-to-date book should be required reading for everyone interested in applying cutting-edge data-driven modeling to the field of oncology."—Thomas S. Deisboeck, MD MBA, Harvard Medical School"This book provides an important introduction to the emerging field of physical oncology. It examines cancer growth and treatment outcomes in the context of physical and biological processes across microscopic and macroscopic scales. The work is at the forefront of the convergence between physical science and cancer research. Seminal work by the authors and their collaborators from medicine, biology, engineering, mathematics, and physics discussed in this book includes the development of "master equations" from first principles to quantify penetration of free drugs and nanoparticles across tumor tissue, and relating these ideas to their potential for impact on patients. This book is a "must-read" for researchers interested in applying principles of physical sciences to cancer biology."—Anil K. Sood, MD, Departments of Gynecologic Oncology & Reproductive Medicine and Cancer Biology, UT M. D. Anderson Cancer Center"This timely book presents and discusses a range of highly promising, clinically relevant mathematical models of cancer progression and treatment. The authors use bio-physical laws informed by biological measurements to describe the processes of tumor growth and drug transport in tumor tissue to make predictions of outcomes for patients. Their work is informed by quantitative measurements from standard-of-care diagnostics, such as CT, histopathology, and MRI. In doing so, they seek to render individualized rubrics for each patient, based on his or her specific tumor characteristics. This provides a fresh take on the modern concept of "Precision Medicine." The pioneering models described here can pave the way for new, accurate clinical decision tools, which can be used by physicians to predict and thus optimally plan current and new individualized treatment strategies for patients."—Anirban Maitra, MBBS, Sheikh Khalifa Bin Zayed Al Nahyan Distinguished University Chair in Cancer Research, UT M. D. Anderson Cancer Center "During the past decade, innovative researchers have applied principles of engineering and physics to cancer research, in an emerging field known as physical oncology. This multidisciplinary research effort has led to encouraging results towards a better understanding of different aspects of cancer biology and oncology, from quantitative understanding of tumor growth and progression to improved detection and the treatment of cancer. This book introduces and discusses the advances made at the interface of engineering/physical sciences and oncology and explores the new frontiers in this field. The chapters are well written and I am especially impressed by the approach to developing accurate mathematical predictions of tumor drug response in experiments and in patients. I think this book is a significant contribution towards the biomedical community's efforts to improve its quantitative understanding of the treatment of cancer. I hope the book will encourage more scientists to enter the field of physical oncology."—Sanjiv Sam Gambhir, MD, PhD, Stanford University School of Medicine"The application of concepts and tools from the physical sciences will fundamentally change our understanding of cancer. These novel insights will impact the way we diagnose malignant tumors and, ultimately, they should lead to new and patient-specific paths to treat the disease more successfully. The authors are at the forefront of this most promising endeavor and they have produced a book that, ranging from chemotherapy response to immunotherapy modeling, highlights both critical research accomplishments and early clinical applications. This up-to-date book should be required reading for everyone interested in applying cutting-edge data-driven modeling to the field of oncology."—Thomas S. Deisboeck, MD MBA, Harvard Medical School"This book provides an important introduction to the emerging field of physical oncology. It examines cancer growth and treatment outcomes in the context of physical and biological processes across microscopic and macroscopic scales. The work is at the forefront of the convergence between physical science and cancer research. Seminal work by the authors and their collaborators from medicine, biology, engineering, mathematics, and physics discussed in this book includes the development of "master equations" from first principles to quantify penetration of free drugs and nanoparticles across tumor tissue, and relating these ideas to their potential for impact on patients. This book is a "must-read" for researchers interested in applying principles of physical sciences to cancer biology."—Anil K. Sood, MD, Professor, Departments of Gynecologic Oncology & Reproductive Medicine and Cancer Biology, UT M. D. Anderson Cancer Center"This timely book presents and discusses a range of highly promising, clinically relevant mathematical models of cancer progression and treatment. The authors use bio-physical laws informed by biological measurements to describe the processes of tumor growth and drug transport in tumor tissue to make predictions of outcomes for patients. Their work is informed by quantitative measurements from standard-of-care diagnostics, such as CT, histopathology, and MRI. In doing so, they seek to render individualized rubrics for each patient, based on his or her specific tumor characteristics. This provides a fresh take on the modern concept of "Precision Medicine." The pioneering models described here can pave the way for new, accurate clinical decision tools, which can be used by physicians to predict and thus optimally plan current and new individualized treatment strategies for patients."—Anirban Maitra, MBBS, Sheikh Khalifa Bin Zayed Al Nahyan Distinguished University Chair in Cancer Research, UT M. D. Anderson Cancer Center "During the past decade, innovative researchers have applied principles of engineering and physics to cancer research, in an emerging field known as physical oncology. This multidisciplinary research effort has led to encouraging results towards a better understanding of different aspects of cancer biology and oncology, from quantitative understanding of tumor growth and progression to improved detection and the treatment of cancer. This book introduces and discusses the advances made at the interface of engineering/physical sciences and oncology and explores the new frontiers in this field. The chapters are well written and I am especially impressed by the approach to developing accurate mathematical predictions of tumor drug response in experiments and in patients. I think this book is a significant contribution towards the biomedical community's efforts to improve its quantitative understanding of the treatment of cancer. I hope the book will encourage more scientists to enter the field of physical oncology."—Sanjiv Sam Gambhir, MD, PhD, Stanford University School of MedicineTable of ContentsWhat Should Be Modeled in Cancer: Milestones for Physical Models. Developing More Successful Cancer Treatments with Physical Oncology. Mathematical Pathology. Mathematical Modeling of Drug Response. Prediction of Chemotherapy Outcome in Patients. Clinical Management of Pancreatic Cancer. Application of Cancer Physics in the Clinic. Tumor Morphological Behavior and Treatment Outcome. Mechanistic Model of Tumor Response to Immunotherapy. Perspectives on Physical Oncology and Future Directions
£86.99
Live Stronger Faster 58 Rezepte gegen Hodenkrebs: Beuge Hodenkrebs vor
Book Synopsis
£14.99
Urban & Fischer/Elsevier Plastischrekonstruktive HauttumorChirurgie
Book Synopsis
£183.20
Nova Science Publishers, Inc. Acute Myeloid Leukemia Diagnosis Prognosis
Book Synopsis
£219.99
Nova Science Publishers, Inc. A Closer Look at Cancer Biomarkers
Book Synopsis
£62.04
Elsevier Science Cancer Stem Cells
Book SynopsisTable of Contents1. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH networkTami J. Kingsbury, MinJung Kim and Curt I. Civin2. Dormancy and cancer stem cells: An enigma for cancer therapeutic targetingSarmistha Talukdar, Praveen Bhoopathi, Luni Emdad, Swadesh Das, Devanand Sarkar and Paul B. Fisher3. Clonal hematopoiesis: Pre-cancer PLUSAlexander J. Silver and Siddhartha Jaiswal4. Assays for functionally defined normal and malignant mammary stem cells Syed M. Musheer Aalam, Philip A. Beer and Nagarajan Kannan5. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapyLisha Xiang and Gregg L. Semenza6. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment Aksinija A. Kogan, Rena G. Lapidus, Maria R. Baer and Feyruz V. Rassool
£104.00
Oxford University Press Mayo Clinic Cases in Neuroimmunology Mayo Clinic
Book SynopsisTrade ReviewThis book is useful for general neurologists for review on the wards and in clinic, as well as neuroimmunologists. * Tzu-Ying Chuang, MD, PhD, (Thomas Jefferson University), DOODY'S *Table of ContentsSection I CNS Demyelinating Disease (Cases 1-21) Case 1 A Woman With Subacute Painful Vision Loss Jiraporn Jitprapaikulsan, MD, M. Tariq Bhatti, MD, Eric R. Eggenberger, DO, and Marie D. Acierno, MD Case 2 Rapidly Progressive Numbness and Weakness After Soft-Tissue Abscess Elia Sechi, MD, and Dean M. Wingerchuk, MD Case 3 Weakness With Neck Flexion Brian G. Weinshenker, MD Case 4 New-Onset Right-Sided Numbness and Double Vision W. Oliver Tobin, MB, BCh, BAO, PhD Case 5 Progressive Left Lower Extremity Weakness and Thoracic Spinal Cord Lesion B. Mark Keegan, MD Case 6 Progressive Spasticity With a Single Magnetic Resonance Imaging Lesion Samantha A. Banks, MD, and Eoin P. Flanagan, MB, BCh Case 7 Fluctuating Vision Loss, Seizures, and Left Parieto-Occipital Mass Alicja Kalinowska-Lyszczarz, MD, PhD, W. Oliver Tobin, MB, BCh, BAO, PhD, Yong Guo, MD, PhD, and Claudia F. Lucchinetti, MD Case 8 Diffuse Pain and Abnormal Brain MRI Findings Andrew McKeon, MB, BCh, MD Case 9 Lesions Found by Chance Dean M. Wingerchuk, MD Case 10 Encephalopathy and Quadriparesis After an Upper Respiratory Tract Infection A. Sebastian Lopez Chiriboga, MD Case 11 Severe Monocular Vision Loss Followed by Gait Difficulty Brian G. Weinshenker, MD Case 12 Multiple Sclerosis and Cognitive Impairment Cristina Valencia-Sanchez, MD, PhD, and Jonathan L. Carter, MD Case 13 New-Onset Gait Difficulty With Kappa Free Light Chains in Cerebrospinal Fluid Maria Alice V. Willrich, PhD, and Ruba S. Saadeh Case 14 A Girl With Back Pain, Paresthesias, and Painful Vision Loss Cecilia Zivelonghi, MD, and Andrew McKeon, MB, BCh, MD Case 15 A Septuagenarian With Progressive Hemiparesis Roman Kassa, MD, and B. Mark Keegan, MD Case 16 Recurrent Demyelinating Episodes I. Vanessa Marin Collazo, MD Case 17 Breakthrough Disease While on Multiple Sclerosis Immunomodulatory Therapy Jonathan L. Carter, MD Case 18 Highly Active Multiple Sclerosis Roman Kassa, MD, and W. Oliver Tobin, MB, BCh, BAO, PhD Case 19 Progressive Gait Difficulties I. Vanessa Marin Collazo, MD Case 20 Progressive Cerebellar Ataxia After Natalizumab Treatment Michel Toledano, MD Case 21 Weakness and Dysarthria After Radiosurgery Andrew McKeon, MB, ChB, MD Section II Autoimmune Neurologic Disorders (Cases 22-52) Case 22 Fatigue, Blurry Vision, and Swollen Optic Nerves Marie D. Acierno, MD, M. Tariq Bhatti, MD, John J. Chen, MD, PhD, and Eric R. Eggenberger, DO Case 23 Progressive, Symmetrical, Painless Visual Loss in an Elderly Woman Eric R. Eggenberger, DO, Marie D. Acierno, MD, M. Tariq Bhatti, MD, and John J. Chen, MD, PhD Case 24 Personality Changes, Cognitive Decline, and Jerking Movements A. Sebastian Lopez Chiriboga, MD Case 25 Rapidly Progressive Memory Loss, Mood Change, Mutism, and Abnormal Movements Shailee S. Shah, MD, and Marie F. Grill, MD Case 26 Behavioral and Cognitive Changes Followed by Coma Anastasia Zekeridou, MD, PhD Case 27 Episodic Hemiparesis, Cognitive Decline, and Seizures in a Woman With Pernicious Anemia Cristina Valencia-Sanchez, MD, PhD, and Andrew McKeon, MB, BCh, MD Case 28 Rapidly Progressive Dementia and Thyroid Antibodies Amy C. Kunchok, MBBS, MMED, and Eoin P. Flanagan, MB, BCh Case 29 Goosebumps and Memory Loss Jeffrey W. Britton, MD, Bhavya Narapureddy, MBBS, and Divyanshu Dubey, MBBS Case 30 A Patient With Headache and Progressive Tremor Anastasia Zekeridou, MD Case 31 A Man With Flulike Symptoms and Hemorrhagic Brain Lesions Michel Toledano, MD Case 32 Hearing Loss, Imbalance, and Diplopia in a 44-Year-Old Man Michelle F. Devine, MD, Divyanshu Dubey, MBBS, and Sean J. Pittock, MD Case 33 Chorea, Ataxia, and Disturbed Sleep John C. Feemster, and Erik K. St. Louis, MD, MS Case 34 Rapidly Progressive Gait and Coordination Difficulties Andrew McKeon, MB, BCh, MD Case 35 Dancelike Movements in a Patient With a History of Rash Andrew McKeon, MB, BCh, MD Case 36 Body Spasms in a Woman With Thyroid Disease Andrew McKeon, MB, BCh, MD Case 37 Stiffness, Spasms, and Frequent Falls in a 41-Year-Old Man Michelle Devine, MD, and A. Sebastian Lopez Chiriboga, MD Case 38 Rapid-Onset Weakness and Numbness in a Patient With Systemic Lupus Erythematosus Floranne C. Ernste, MD Case 39 Progressive Quadriparesis and Cancer Elia Sechi, MD, and Eoin P. Flanagan, MB, BCh Case 40 Progressive Numbness, Burning Pain, Imbalance, and Dryness Shahar Shelly, MD, and Divyanshu Dubey, MBBS Case 41 Ascending Painful Paresthesias, Progressive Ataxia, and Bilateral Foot Drop Rocio Vazquez Do Campo, MD, and Divyanshu Dubey, MBBS Case 42 Painless, Symmetric, Ascending Weakness and Sensory Loss Christopher J. Klein, MD Case 43 Difficult-to-Treat Polyradiculoneuropathy Marcus V. R. Pinto, MD, MS, and P. James B. Dyck, MD Case 44 Autoimmune Peripheral Nervous System Hyperexcitability Christopher J. Klein, MD Case 45 Orthostatism, Constipation, and Early Satiety Kamal Shouman, MD, and Eduardo E. Benarroch, MD Case 46 Constipation and Syncope Michelle F. Devine, MD, and Sean J. Pittock, MD Case 47 Bulbar-Predominant Weakness Jennifer A. Tracy, MD, and Vanda A. Lennon, MD, PhD Case 48 Difficulty Climbing the Stairs Anastasia Zekeridou, MD, PhD, and Vanda A. Lennon, MD, PhD Case 49 Rapidly Progressive Proximal Weakness Teerin Liewluck, MD, and Margherita Milone, MD, PhD Case 50 Progressive Weakness and Rash Margherita Milone, MD, PhD, and Teerin Liewluck, MD Case 51 "Restlessness" After Cancer Diagnosis and Treatment Anastasia Zekeridou, MD, PhD Case 52 Sudden Onset of Diplopia and a Skeletal Muscle Antibody John R. Mills, PhD Section III Other Inflammatory CNS Disorders and Neuroimmunologic Mimics (Cases 53-83) Case 53 Diplopia, Orbital Pain, and Vision Loss in a Middle-Aged Woman Lauren M. Webb, and Eoin P. Flanagan, MB, BCh Case 54 A Young Man With Visual Field Loss, Decreased Hearing, and Confusion M. Tariq Bhatti, MD, Eric R. Eggenberger, DO, Marie D. Acierno, MD, and John J. Chen, MD, PhD Case 55 A Woman With Progressive Gait Difficulty and White Matter Abnormalities Adrian Budhram, MD, and Ralitza H. Gavrilova, MD Case 56 Progressive Asymmetrical Limb Impairment and Cognitive Decline With Leukoencephalopathy B. Mark Keegan, MD Case 57 A Woman With Fever, Confusion, and Seizures Michel Toledano, MD Case 58 Encephalopathy With Alternating Hemispheric MRI Abnormalities Andrew McKeon, MB, BCh, MD Case 59 Rapid-Onset Hemibody Sensory Loss, Incoordination, and Muscle Jerking Andrew McKeon, MB, BCh, MD, and Nicholas L. Zalewski, MD Case 60 A History of Sarcoidosis and a New Brain Lesion Andrew McKeon, MB, BCh, MD, and Julie E. Hammack, MD Case 61 Headache and Hemiparesis in Middle Age Catalina Sanchez Alvarez, MD, and Kenneth J. Warrington, MD Case 62 Subacute Cognitive Decline in an 86-Year-Old Woman With Prior Lobar Intracerebral Hemorrhage Stephen W. English Jr, MD, MBA, and James P. Klaas, MD Case 63 A 75-Year-Old Man With 5 Days of Progressive Gait Difficulties and Confusion Julie E. Hammack, MD Case 64 Night Sweats and Paraparesis David N. Abarbanel, MD, and Ivan D. Carabenciov, MD Case 65 A Woman With Headaches and a Tumefactive Brain Lesion Andrew McKeon, MB, BCh, MD Case 66 Behavioral Change, Seizures, and Temporal Lobe Lesion Stuart J. McCarter, MD, and Andrew McKeon, MB, BCh, MD Case 67 A Young Woman With Vessel Dissection and Brainstem Lesions Burcu Zeydan, MD, and Orhun H. Kantarci, MD Case 68 Headache, Uveitis, and Leptomeningeal Enhancement Orhun H. Kantarci, MD Case 69 Weakness and Punctate Enhancement W. Oliver Tobin, MB, BCh, BAO, PhD Case 70 Bilateral Paresthesias in Crohn Disease Amy C. Kunchok, MBBS, and Andrew McKeon, MB, BCh, MD Case 71 Seizures and Enhancing Brain Lesions Josephe Archie Honorat, MD, PhD, and Andrew McKeon, MB, BCh, MD Case 72 A Man With Recurrent Headache and Focal Neurologic Deficits Jaclyn R. Duvall, MD, and Jerry W. Swanson, MD, MHPE Case 73 Headache, Radicular Pain, and Enhancing Lesions W. Oliver Tobin, MB, BCh, BAO, PhD Case 74 Seizures 3 Months After Endarterectomy Andrew McKeon, MB, BCh, MD, and Robert D. Brown Jr, MD, MPH Case 75 Progressive Bilateral Arm Pain, Gait Disturbance, Constipation, and Urinary Retention Ivan D. Carabenciov, MD, and Michael W. Ruff, MD Case 76 A Woman With Subacute Numbness of the Trunk, Arms, and Legs Eoin P. Flanagan, MB, BCh Case 77 A Septuagenarian With Progressive Lower Extremity Weakness and Pain Nicholas L. Zalewski, MD Case 78 Acute Quadriparesis in a Smoker Nicholas L. Zalewski, MD Case 79 A 25-Year-Old Man With Recurrent Back Pain and Rapid-Onset Paraplegia Nicholas L. Zalewski, MD Case 80 Progressive Myelopathy After Neck Pain Eoin P. Flanagan, MB, BCh Case 81 Progressive Imbalance and Visual Impairment in a Patient With Diabetes Neeraj Kumar, MD Case 82 Progressive Myelopathy After Spine Surgery Andrew McKeon, MB, BCh, MD, and Nicholas L. Zalewski, MD Case 83 Altered Mental Status During the COVID-19 Pandemic Sara Mariotto, MD, Silvia Bozzetti, Maria Elena De Rui, Fulvia Mazzaferri, Andrew McKeon, MB, BCh, MD, and Sergio Ferrari Section IV Questions and Answers Section I: Questions, Answers, Suggested Reading Section II: Questions, Answers, Suggested Reading Section III: Questions, Answers, Suggested Reading
£66.00
Oxford University Press Inc Cancer Survivors in Later Life
Book SynopsisCancer has been called a disease of the elderly, with advancing age as a risk factor for most cancers and half of all malignancies occurring after the age of 65. With the recent advances in medical care, people are living longer after cancer treatments. The number of cancer survivors is projected to reach 19 million by 2024. Cancer Survivors in Later Life blends existing research with the findings from a major National Cancer Institute-funded study focusing on older adult cancer survivors and the challenges they face. The book is organized into eight chapters that reflect some of the key themes in larger psycho-social oncology, medical oncology, gerontology, and family research literatures. These include cancer and aging, cancer survivorship in later life, cancer and the social self, health and quality of life, functioning and disability, psycho-social distress, adaptation, appraisal and coping, and altered life perspectives after cancer.Within each chapter, the theme introduced is discussed in terms of the prominent foundational and recent research published by those working in the field. This is supplemented by findings from over 20 years of Dr. Deimling''s research in collaboration with colleagues at Cancer Survivors Research Program (CSRP) at Case Western Reserve. In addition to the quantitative data presented, each chapter provides narratives that draw on the lived experiences of respondents in these studies in their own words, making Cancer Survivors in Later Life a multifaceted resource. Readers will find it a state-of-the-art reference for studying the key challenges older adult survivors face in terms of their health, living with cancer, and coping with its after-effects.
£999.99
Elsevier Health Sciences Lung Cancer Rehabilitation
Book SynopsisTable of ContentsEpidemiology Genetics and pathophysiology Clinical assessment of the Lung Cancer Patient Lung Cancer Surgery Radiation Therapy Chemotherapy Immunotherapy Principles of Rehabilitation of the Lung Cancer patient-inpatient, outpatient and home Pre-habilitation of the Lung Cancer Patient Role of Physical Therapy Role of Occupational Therapy Pain Syndromes Lymphedema Treatment of Anxiety and Depression Integrative Care Nutritional Rehabilitation The role of Palliative Care Multidisciplinary Approach
£71.09
Elsevier Health Sciences Diagnosis and Treatment of Gastrointestinal
Book SynopsisTable of ContentsSquamous Cell Carcinoma of the Esophagus Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment Endoscopic Evaluation and Management of Cholangiocarcinoma Pancreatic Cystic Neoplasms Familial Pancreatic Cancer Colorectal Cancer Screening in a Changing World Approach to Familial Predisposition to Colorectal Cancer A Gastroenterologist's Approach to the Diagnosis and Management of Gastrointestinal Stromal Tumors Gastroenteropancreatic Neuroendocrine Tumors Cancer in Inflammatory Bowel Disease The Microbiome in Gastrointestinal Cancers
£70.19
Elsevier Health Sciences Pancreatobiliary Pathology An Issue of Surgical
Book SynopsisTable of ContentsThe Diagnostic Challenge of Evaluating Small Biopsies from the Pancreatobiliary System Integrating Molecular Analysis into the Pathologic Evaluation of Pancreatic Cysts The Cytomorphologic and Molecular Assessment of Bile Duct Brushing Specimens Advances in the Surgical Treatment of Pancreatic Cancer The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice Total Pancreatectomy with Islet Autotransplantation: New Insights on the Pathology and Pathogenesis of Chronic Pancreatitis from Tissue Research The Histopathology of Neoadjuvant-Treated (NAT) Pancreatic Ductal Adenocarcinoma The Molecular Pathogenesis and Targeted Therapies for Cholangiocarcinoma Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms of the Pancreas The Clinical and Pathologic Features of Intracholecystic Papillary-Tubular Neoplasms of the Gallbladder
£51.29
Elsevier Science Proteomics
Book SynopsisTable of Contents1. Cancer proteomics: An overview2. Proteomics: A groundbreaking development in cancer biology3. Proteomics: Landmark advancements and challenges in cancer biomarker and drug discovery4. Proteomic profiling and its applications in cancer research5. Role of Proteomics in surgical oncology6. Applications of Mass spectrometry in understanding cancer proteomics7. Proteomics: A modern tool for identifying therapeutic targets in different type of carcinomas8. Cancer proteomics: Application of case studies in diverse cancers9. A shift from Shotgun proteomic to Targeted proteomics: A step forward in cancer research10. Applications of proteomics in cancer diagnosis11. Single-cell proteomics: Role in cancer immunotherapy12. Applications of Next-Generation Proteomics in cancer research13. Data-Independent acquisition: Application in cancer proteomics14. Applications of plasma membrane proteomics in the discovery of cancer biomarkers15. Cancer proteomic assay development: A hypothesis-driven approach16. Utility of Proteomics and phospho-proteomics in the tailored medication of cancer17. Translation of proteomic research into clinical application for cancer treatment18. Cancer proteomics: current status, challenges, and future outlook
£999.99
Elsevier Science Understanding Cancer
Book SynopsisTable of Contents1. A brief tour guide to cancer diseasePadmini Bisoyi 2. Malignant tumors – as cancerPadmini Bisoyi 3. Etiology of cancerAmena Mahmood and Rahul Srivastava4. Medical diagnosis of cancerAmena Mahmood and Rahul Srivastava5. Molecular mechanisms in cancer developmentArun Kumar Kashyap and Sumit K. Dubey6. Cancer and cell cycleRohini R. Nair and Suresh S. Yadav7. Cancer and apoptosisShyam B. Prasad8. Fundamentals of cell metabolism and cancerRagunathan Devendran, Vignesh Ramesh, and Prabu Gnanasekaran9. Cancer epigenetics: DNA methylation and histone modificationsTapan Sharma10. Cancer epigenetics: Chromatin remodeling and other epigenetic mechanismsTapan Sharma11. Alteration in major cell signaling pathways in CancerShweta Pandey, Nisha, Buddhi Prakash Jain12. Cancer stem cellsMd. Sabir Ali13. Cancer and regulation of gene expression Tapan Sharma14. Chemotherapy and radiation therapy for CancerSivapar V. Mathan, Mohit Rajput, Rana P. Singh15. Cancer gene therapies progress in pre and postgenomics eraDeepak Babu, and Amit Ranjan16. Hormone therapy for cancer treatmentSavita Devi17. Natural herbal products for cancer therapyDurgeshwer Singh, Khushboo Kumari and Salim Ahmed18. Immunotherapy for cancer treatmentKundan K. Rajak
£103.50
Taylor & Francis Ltd Advanced Skin Cancer
Book SynopsisAdvanced skin cancer is one that has already metastasized beyond its primary origin, or one that has invaded underlying tissues such that surgical resection either is technically impossible or would lead to an unacceptable functional or cosmetic outcome. These skin cancers present a complex problem that requires the input of multiple specialties to delineate the best management plan. National guidelines utilize the best available data to guide management decisions. However, there is considerable leeway within the guidelines, enabling the ultimate care decision to be molded to best fit each individual patient. This book aims to provide instructional examples of patient cases where the input of the multidisciplinary team is critical in providing the most suitable care plan for the patient.CONTENTS: Melanoma * Squamous Cell Carcinoma * Basal Cell Carcinoma * Cutaneous Lymphoma * Kaposi's Sarcoma * Dermatofibrosarcoma Protuberans * Merkel Cell Carcinoma * Rare CaTrade Review"...provides an understanding of the depth of decision-making involved by multiple specialists in the field".- Doody's ReviewTable of ContentsMelanoma * Squamous Cell Carcinoma * Basal Cell Carcinoma * Cutaneous Lymphoma * Kaposi’s Sarcoma * Dermatofibrosarcoma Protuberans * Merkel Cell Carcinoma * Rare Cancer Presentations
£105.00
Taylor & Francis Ltd AutoSegmentation for Radiation Oncology
Book SynopsisThis book provides a comprehensive introduction to current state-of-the-art auto-segmentation approaches used in radiation oncology for auto-delineation of organs-of-risk for thoracic radiation treatment planning. Containing the latest, cutting edge technologies and treatments, it explores deep-learning methods, multi-atlas-based methods, and model-based methods that are currently being developed for clinical radiation oncology applications. Each chapter focuses on a specific aspect of algorithm choices and discusses the impact of the different algorithm modules to the algorithm performance as well as the implementation issues for clinical use (including data curation challenges and auto-contour evaluations). This book is an ideal guide for radiation oncology centers looking to learn more about potential auto-segmentation tools for their clinic in addition to medical physicists commissioning auto-segmentation for clinical use. Features: Up-to-dateTrade Review "This textbook provides a comprehensive overview of multi-atlas and deep learning approaches to auto-contouring. Furthermore, key questions on clinical implementation are considered. The first introductory chapter describes the main focus of this book being the Thoracic Auto-segmentation Challenge held as an event of the 2017 Annual Meeting of the American Association of Physicists in Medicine (AAPM). Several challenge participants contributed a chapter to this book, addressing a specific strength of their segmentation algorithms. The lack of broad clinical introduction of auto-segmentation, which according to the editors is partly due to the lack of commissioning guidelines, made them dedicate the third part of the book to clinical implementation concerns. The book is written for everyone working in the field of auto-segmentation in radiotherapy. The experienced editors are from academia, clinical physics, and industry; their broad experience gives excellent perspective to this book…This book was useful toward improving my understanding of deep learning-based methods in medical image segmentation. To the best of my knowledge, this is the only textbook available on auto-segmentation dedicated to radiation oncology. Practical concerns and recommendations for implementation make this textbook a must-have for every radiation oncology department." — Charlotte Brouwer, M.Sc. in Medical Physics (December, 2021) Table of Contents Contents Foreword I..........................................................................................................................................ix Foreword II........................................................................................................................................xi Editors............................................................................................................................................. xiii Contributors......................................................................................................................................xv Chapter 1 Introduction to Auto-Segmentation in Radiation Oncology.........................................1 Jinzhong Yang, Gregory C. Sharp, and Mark J. Gooding Part I Multi-Atlas for Auto-Segmentation Chapter 2 Introduction to Multi-Atlas Auto-Segmentation......................................................... 13 Gregory C. Sharp Chapter 3 Evaluation of Atlas Selection: How Close Are We to Optimal Selection?................. 19 Mark J. Gooding Chapter 4 Deformable Registration Choices for Multi-Atlas Segmentation............................... 39 Keyur Shah, James Shackleford, Nagarajan Kandasamy, and Gregory C. Sharp Chapter 5 Evaluation of a Multi-Atlas Segmentation System......................................................49 Raymond Fang, Laurence Court, and Jinzhong Yang Part II Deep Learning for Auto-Segmentation Chapter 6 Introduction to Deep Learning-Based Auto-Contouring for Radiotherapy................ 71 Mark J. Gooding Chapter 7 Deep Learning Architecture Design for Multi-Organ Segmentation......................... 81 Yang Lei, Yabo Fu, Tonghe Wang, Richard L.J. Qiu, Walter J. Curran, Tian Liu, and Xiaofeng Yang Chapter 8 Comparison of 2D and 3D U-Nets for Organ Segmentation.................................... 113 Dongdong Gu and Zhong Xue Chapter 9 Organ-Specific Segmentation Versus Multi-Class Segmentation Using U-Net....... 125 Xue Feng and Quan Chen Chapter 10 Effect of Loss Functions in Deep Learning-Based Segmentation............................ 133 Evan Porter, David Solis, Payton Bruckmeier, Zaid A. Siddiqui, Leonid Zamdborg, and Thomas Guerrero Chapter 11 Data Augmentation for Training Deep Neural Networks ........................................ 151 Zhao Peng, Jieping Zhou, Xi Fang, Pingkun Yan, Hongming Shan, Ge Wang, X. George Xu, and Xi Pei Chapter 12 Identifying Possible Scenarios Where a Deep Learning Auto-Segmentation Model Could Fail...................................................................................................... 165 Carlos E. Cardenas Part III Clinical Implementation Concerns Chapter 13 Clinical Commissioning Guidelines......................................................................... 189 Harini Veeraraghavan Chapter 14 Data Curation Challenges for Artificial Intelligence................................................ 201 Ken Chang, Mishka Gidwani, Jay B. Patel, Matthew D. Li, and Jayashree Kalpathy-Cramer Chapter 15 On the Evaluation of Auto-Contouring in Radiotherapy.......................................... 217 Mark J. Gooding Index............................................................................................................................................... 253
£45.99
Taylor & Francis Ltd Monte Carlo in Heavy Charged Particle Therapy
Book SynopsisThis book explores the current difficulties and unsolved problems in the field of particle therapy and, after analysing them, discusses how (and if) innovative Monte Carlo approaches can be used to solve them. Each book chapter is dedicated to a different sub-discipline, including multi-ion treatments, flash-radiotherapy, laser-accelerated beams, nanoparticles effects, binary reactions to enhance radiobiology, and space-related issues. This is the first book able to provide a comprehensive insight into this exciting field and the growing use of Monte Carlo in medical physics. It will be of interest to graduate students in medicine and medical physics, in addition to researchers and clinical staff.Key Features: Explores the exciting and interdisciplinary topic of Monte Carlo in particle therapy and medicine Addresses common challenges in the field Edited by an authority on the subject, with chapter contributions from spTable of Contents Chapter 1: The Monte Carlo Method and Its Applications to Heavily Charged Particle Therapy. Chapter 2: Applications of Monte Carlo Calculations in Clinical Dosimetry of Proton and Ion Beams. Chapter 3: Solving Range Uncertainties with Gamma Prompt/Charged Particle Prompt. Chapter 4: Macroscopic and microscopic calculation approaches for LET calculations. Chapter 5: Low energy inelastic process in hadrontherapy. Chapter 6: Experimental Data of Nuclear Fragmentation for Validating Monte Carlo Modes: Present Availability and Lacks. Chapter 7: Quality assurance in particle therapy with PET. Chapter 8: Radioactive beams for ion therapy: Monte Carlo simulations and experimental verifications. Chapter 9: Monte Carlo and Microdosimetry in particle radiotherapy. Chapter 10: Monte Carlo to link RBE with radiation quality quantities. Chapter 11: Physical and Biological Impact of Projectile and Target Fragmentation. Chapter 12: Monte Carlo characterisation of nanoparticle radio-enhancement for hadron therapy. Chapter 13: Increasing particle therapy biological effectiveness by nuclear reaction-driven binary strategies. Chapter 14: Monte Carlo simulations for Targeted Alpha Therapy. Chapter 15: Experimental and modelling challenges in FLASH radiotherapy with Monte Carlo Methods. Chapter 16: Towards Multiple Ion Applications in Particle Therapy. Chapter 17: Monte Carlo for chemistry in radiation biology. Chapter 18: Recent developments in the TRAX particle track structure code. Chapter 19: Machine Learning for Monte Carlo Simulations. Chapter 20: Speed-up MC in charged particle applications. Chapter 21: Monte Carlo and Analytical codes for Dose planning and recalculation: limits and differential advantages.
£152.56
Elsevier Science Pancreatic Cancer Basic Mechanisms and Therapies
Book SynopsisTable of Contents1. Notch signaling pathway in pancreatic tumorigenesis Keli Xu 2. EMT in Pancreatic Ductal Adenocarcinoma Azeddine Atfi 3. Review of Immunocompetent In-vivo Models of PDAC OR Stromal Microenvironment Impact on Pacreatic Cancer Progression and Metastasis Vignesh Vudatha and Jose Trevino 4. Interplay between MAP Kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer Ajay Rana and Kumar Sandeep 5. KRAS in pancreatic cancer: Emerging therapeutic strategies Daohong Zhou 6. Disparities in Pancreatic Cancer Clinical Trials Allison Neal Martin and Rebecca A. Snyder 7. Tumor heterogeneity: an oncogenic driver of PDAC progression and therapy resistance under stress conditions Esha Madan 8. Oncogenic Signaling Pathways in Pancreatic Ductal Adenocarcinoma Kedar Nath Natarajan 9. Chemoresistance in Pancreatic Ductal Adenocarcinoma: Overcoming Resistance to Therapy Praveen Bhoopathi 10. Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma Rajan Gogna
£113.05
Elsevier Science OncoPalliative Care Essentials
Book Synopsis
£120.60
Elsevier Health Sciences Breast Cancer An Issue of HematologyOncology
Book SynopsisTable of ContentsDisparities in Breast Cancer Outcomes and How to Resolve Them Testing for Inherited Susceptibility to Breast Cancer Breast Cancer Pathology in the Era of Genomics Breast Cancer Pathology in the Era of Genomics Role of Ovarian Suppression in Early Premenopausal Breast Cancer Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer Biology and Treatment of HER2-Low Breast Cancer Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Multidisciplinary Management of Brain Metastasis from Breast Cancer Systemic Therapy for Hereditary Breast Cancers Evidence-Based Guidance for Breast Cancer Survivorship
£77.39
Elsevier Health Sciences Lung Cancer An Issue of HematologyOncology
Book SynopsisTable of ContentsState of the Art of Pathologic and Molecular Testing Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer Advances in Surgical Techniques for Lung Cancer Nonsurgical Therapy for Early-Stage Lung Cancer The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer Locally Advanced Lung Cancer First-Line Treatment of Driver-Negative Non-Small Cell Lung Cancer Targeted Therapy for Non-Small Cell Lung Cancer: First Line and Beyond What Is New in Small Cell Lung Cancer Lung Cancer Supportive Care and Symptom Management New Therapies on the Horizon
£77.39
Hachette Books The Cancer Revolution
Book SynopsisFrom the Founder and Medical Director of the centre for New Medicine and the Cancer centre for Healing in Irvine, California: an integrative approach to treating (and preventing) cancer, based on 6 Revolutionary Findings, with a practical program and strategies that have been used with extraordinary success.Trade Review"Dr. Connealy understands the role of nutrition, epigenetics, and integrative approaches in healing cancer and even preventing cancer. Cancer is not a death sentence. There is always hope, and this book will empower you with knowledge that just might save your life or the life of a loved one." ?Ty M. Bollinger, author of the New York Times bestselling The Truth About Cancer, documentary film producer "Being diagnosed with cancer never needs to become a death sentence. In this groundbreaking book, Dr. Leigh Erin Connealy provides practical, easy-to-implement strategies that can complement your conventional plan to pave the path for healing and vitality. Highly recommended reading."--JJ Virgin, New York Times bestselling author of The Virgin Diet "The Cancer Revolution provides lifesaving facts and information; you cannot receive optimal cancer care without knowing what is in this book. Its empowering information will help ensure that no one will have to settle for inadequate and outdated forms of mainstream cancer treatment."--Garry F. Gordon, MD, DO, MD(H.) "The Cancer Revolution enables everyone to understand and take responsibility for their health and their role in prevention of disease. It is truly an outstanding guide of how to create health and maintain wellness from a personal and professional stand point."--Paul Fisher, Biotics Research
£999.99
CRC Press Surface Guided Radiation Therapy
Book SynopsisSurface Guided Radiation Therapy provides a comprehensive overview of optical surface image guidance systems for radiation therapy. It serves as an introductory teaching resource for students and trainees, and a valuable reference for medical physicists, physicians, radiation therapists, and administrators who wish to incorporate surface guided radiation therapy (SGRT) into their clinical practice. This is the first book dedicated to the principles and practice of SGRT, featuring: Chapters authored by an internationally represented list of physicists, radiation oncologists and therapists, edited by pioneers and experts in SGRT Covering the evolution of localization systems and their role in quality and safety, current SGRT systems, practical guides to commissioning and quality assurance, clinical applications by anatomic site, and emerging topics including skin mark-less setups. Several dedicated chapters on SGRTTrade Review “This book provides comprehensive, technically orientated information of surface guided radiation therapy, a rapidly emerging technology in radiotherapy. Authored by medical physicists, radiation therapists, and radiation vendors, this book covers all aspects of surface guided radiation therapy, with the intention of this new technology being implemented clinically in a safe and efficient manner. The book will likely be of greatest interest to residents of medical physics and radiation oncology as a textbook to gain general knowledge in the field, as well as to medical physicists as a reference book when implementing this new technology clinically. It may also be of interest to administration professionals who are considering expanding clinical practice and would like a general overview. This book is a timely addition to radiotherapy literature with a comprehensive collection of information and knowledge that has been gained in this emerging new field. While there are many research publications about surface guided radiotherapy already, this is the first book that encompasses technical information related to current SGRT systems on the market.” —Shuying Wan, PhD (Sidney Kimmel Cancer Center-Thomas Jefferson University) in Doody’s Core Titles Review 2022. Table of Contents Contents Preface, xi Acknowledgments, xiii Contributors, xv Chapter 1 ◾ A History of Surface Guidance Methods in Radiation Therapy 1 Jeremy D. P. Hoisak and Todd Pawlicki Chapter 2 ◾ Safety and Quality Improvements with SGRT 25 Hania A. Al-Hallaq and Bill J. Salter Chapter 3 ◾ Technical Overview and Features of the C-RAD Catalyst™ and Sentinel™ Systems 51 Karl Rasmussen, Victoria Bry, and Nikos Papanikolaou Chapter 4 ◾ Technical Overview and Features of the Varian IDENTIFY ™ System 73 Raymond Schulz, Chris Huyghe, Lisa Hampton, Delena Hanson, Michael stead, and Thomas Speck Chapter 5 ◾ Technical Overview and Features of the Vision RT AlignRT® System 95 Benjamin Waghorn Chapter 6 ◾ Commissioning and Routine Quality Assurance of the C-RAD Catalyst™ and Sentinel™ 4D-CT Systems 117 Alonso N. Gutierrez and Dennis N. Stanley Chapter 7 ◾ Commissioning and Routine Quality Assurance of the Varian IDENTIFY ™ System 137 Hui Zhao and Adam B. Paxton Chapter 8 ◾ Commissioning and Routine Quality Assurance of the Vision RT AlignRT® System 157 Guang Li Chapter 9 ◾ Surface Guidance for Whole Breast and Partial Breast: Technical Aspects 187 Laura Padilla Chapter 10 ◾ Surface Guidance for Breast: Deep Inspiration Breath Hold 209 Xiaoli Tang Chapter 11 ◾ Breast Cancer Outcomes and Toxicity Reduction with SGRT 227 Orit Kaidar-Person, Icro Meattini, Marianne C. Aznar, and Philip Poortmans Chapter 12 ◾ Surface Guidance for Stereotactic Radiosurgery and Radiotherapy: Technical Aspects 239 Laura Cerviño and Grace Gwe-Ya Kim Chapter 13 ◾ Clinical Outcomes of Intracranial Surface-Guided Stereotactic Radiosurgery 255 Douglas a. rahn iii Chapter 14 ◾ Risk Analysis for SGRT-Based SRS/SRT 269 Ryan Manger Chapter 15 ◾ SBRT and Respiratory Motion Management Strategies with Surface Guidance 279 Michael J. Tallhamer Chapter 16 ◾ The Use of SGRT for SBRT without Respiratory Gating 303 Ryan Foster and John Heinzerling Chapter 17 ◾ Head and Neck 319 Bo Zhao Chapter 18 ◾ Surface Image Guidance for Treatment of Extremities 339 David p. Gierga Chapter 19 ◾ Application of SGRT in Pediatric Patients: The CHLA Experience 351 Arthur J. Olch, Alisha Chlebik, and Kenneth Wong Chapter 20 ◾ Skin Mark-Less Patient Setup: A Physicist’s Perspective 367 Vanessa Panettieri, Sandra Paul, and Catherine Russell Chapter 21 ◾ Tattoo/Skin Mark-Less Setups Using SGRT: A Radiation Therapist’s Perspective 391 Jacqueline Dorney Chapter 22 ◾ Introducing SGRT into the Clinic: A Radiation Therapist’s Perspective 399 Ellen Herron and Daniel Bailey Chapter 23 ◾ SGRT for Proton Therapy 421 Adam B. Paxton Chapter 24 ◾ Integration of Surface Imaging with Tomographic and Bore-Type Gantry Treatment Systems 437 Lu
£45.99
Taylor & Francis Childrens Palliative Nursing Care
Book SynopsisNursing is an essential component of childrenâs palliative care and palliative care is an essential aspect of nursing. Yet the complex inter-disciplinary nature of palliative care brings into sharp focus the work nurses undertake with others in delivering palliative care. This is, however, a book by nurses for nurses.This comprehensive text presents the essential knowledge and skills required by nurses providing this invaluable care to a growing number of children. The chapters are mapped to the Childrenâs Palliative Care Education and Training standards. These are endorsed by the International Childrenâs Palliative Care Network, a major partner with the World Health Organization in the push to make childrenâs palliative care a universal health right. In its three Parts, Children's Palliative Nursing Care covers public and universal care, core nursing and specialist care. The chapters can be read individually or cumulatively to move from engagement in public health a
£35.99
Taylor & Francis Ltd 50 Landmark Papers every Breast Surgeon Should
Book SynopsisThere has been an exponential increase in the volume and quality of published research relating to breast disease over the past decades. This book identifies the 50 key scientific articles in the field of breast disease and breast surgery and examines their importance and impact on current clinical care.Among thousands of articles, a small fraction are truly ''game changing''. Such studies form the foundations of breast surgery today, and the selection of papers within this book provide the 50 landmark papers every 21st-century breast surgeon needs to know. A commentary to each carefully selected paper explains why these papers are so important, thus providing every surgeon with the foundation stones of knowledge in this fast-moving area.A valuable reference not only to the established surgeon, but also to breast surgery residents and trainees, as well as to more experienced surgeons as they continue to learn new techniques and approaches and to improve their knowledge
£34.99
Taylor & Francis The Biological Basis of Cancer
Book SynopsisIntroducing the biology of neoplastic disorders, this accessible book looks at how cancer damages the body, and how the treatments work. Updated with the most recent research evidence, this unique text explains the basic biology of neoplastic disease; discusses the biology of the wide range of common cancers, now including neurological disorders; identifies and explains the biological causes of cancer, with a focus on genetics, hormones, and environmental factors; explains drug action in chemotherapy and analgesia; discusses the role of nutrition in neoplastic disorders and their treatment. Presenting the essential knowledge for working with cancer patients and their families, this textbook is an important read for those working in cancer care or undertaking study in this area.
£43.99
CRC Press Proton Therapy Physics
Book SynopsisExpanding on the highly successful previous two editions, this third edition of Proton Therapy Physics has been updated throughout and includes several new chapters on âœAdaptive Proton Therapyâ, âœImaging for Planningâ, âœFlash Proton Therapyâ, and âœOutcome Modelling for Patient Selectionâ.Suitable for both newcomers in medical physics and more seasoned specialists in radiation oncology, this book provides an in-depth overview of the physics of this radiation therapy modality, eliminating the need to dig through information scattered across medical physics literature.After tracing the history of proton therapy, the book explores the atomic and nuclear physics background necessary for understanding proton interactions with tissue. The text then covers dosimetry, including beam delivery, shielding aspects, computer simulations, detector systems and measuring techniques for reference dosimetry. Important for daily operations, acceptance testing, commissioning, quality a
£84.99
CRC Press Reflections of a Microvascular Plastic Surgeon
Book SynopsisThis book discusses the scope and limitations of complex reconstructive surgery that few Plastic Surgeons master, and that the public rarely encounters, portraying both the technical challenges of advanced reconstructive microsurgery and the human connection between physician and patient as only a master surgeon can convey.For decades, Dr. Deleyiannis has practiced one of the most demanding fields of surgery, treating patients with highly complex and devastating deformities from cancer, trauma, and birth anomalies. Laying the historical foundation of scientific discoveries upon which modern microsurgical practice is based, he takes us âœbehind the scenesâ with real patientsâ stories, highlighting surgical innovation in his own career and the impact on the lives of those he treats.Plastic surgeons and surgeons specialising in reconstruction techniques for patients who have suffered either trauma or cancer will find inspiration and renewed dedication for their specialism
£44.41
Taylor & Francis Ltd Practical Medical Physics
Book SynopsisThis is the first all-encompassing textbook designed to support trainee clinical scientists in medical physics as they start work in a hospital setting whilst undertaking an academic master's course. Developed by practising physicists and experienced academics using their experience of teaching trainee medical physicists, this book provides an accessible introduction to the daily tasks that clinical scientists perform in the course of their work. It bridges the gap between theory and practice, making the book also suitable for advanced undergraduate and graduate students in other disciplines studying modules on medical physics, including those who are considering a career in medical physics through applying to the NHS Scientist Training Programme (STP).Features: Provides an accessible introduction to practical medical physics within a hospital environment Maps to the course content of the Scientist Training Programme in the NHS Trade Review "Peet (University Hospitals of Leicester NHS Trust) and Chung (Univ. of Leicester, Department of Cardiovascular Sciences) assembled an impressive team of contributors to develop a book uniquely positioned to support clinical scientists (also known as medical physicists) working in hospital settings. The book is comprehensive, covering all major medical imaging technologies, e.g., magnetic resonance imaging, ultrasound, X-ray, nuclear medicine. Each chapter first provides a brief summary of the theoretical aspects of the imaging technology at hand, then describes the role of clinical scientists in that field. The work is highly accessible and provides a wealth of practical reference information, including websites, conference recommendations, and easy-to-read tables. Though the terminology and examples are drawn from the National Health Service system in the UK, most of the information is applicable in the context of other developed countries. The book includes a great list of references and informative color figures, and each chapter features a series of thought-provoking case studies. The volume concludes with an interesting discussion of the role of clinical scientists as envisioned for the future. Summing Up: Recommended. Graduate students and professionals. Students in two-year technical programs." —L. S. Cahill, Memorial University of Newfoundland in CHOICE, November 2022. Table of Contents Part 1 Non-ionising imaging Chapter 1. Introduction Chapter 2. Magnetic Resonance Imaging (MRI) Physics Chapter 3. Ultrasound Physics Part 2 Imaging and Therapy using Ionising Radiation Chapter 4. Diagnostic Imaging using X-rays Chapter 5. Nuclear Medicine Imaging and Therapy Chapter 6. Radiotherapy Physics Part 3 Radiation Safety Chapter 7. Radiation Safety
£49.99
Anthea Peries Coping with Cancer Chemotherapy Treatment
Book Synopsis
£999.99